We are studying the effects of IKS03 in patients with advanced B cell non-Hodgkin lymphoma. The goal is to see if it can improve treatment outcomes compared to standard therapies.
Health conditions and diseases that the clinical trial is designed to study and treat.
Advanced B cell Non-Hodgkin Lymphoma is a type of cancer that originates in the lymphatic system, specifically affecting B lymphocytes. It can lead to symptoms such as swollen lymph nodes, fever, night sweats, and unexplained weight loss.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
